Brought to you by:
SVS launches web-based perioperative care guide
The Society for Vascular Surgery (SVS) has launched its “Management Guide on the Perioperative Care of Patients with Vascular Disease,” a multidisciplinary resource for care of patients with vascular disease who require an intervention. The American Society of Anesthesiologists, the…
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed over time, despite high-profile recalls of two dedicated venous stents from the market. Those were among…
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death risks—underpinning current Society for Vascular Surgery (SVS) guidelines recommending routine use of distal embolic protection during…
Algorithm predicts females have higher risk for kidney damage after aneurysm repair
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study finds. Researchers from Michigan Medicine designed an algorithm that can be used prior to endovascular AAA…
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational event for all vascular professionals will be June 14–17 at the National Resort and Convention Center…
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR). Producers of medical devices will have until Dec. 31, 2027, for higher risk…
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower extremity revascularization
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33% reduction in acute limb ischemia and a 15% reduction in major adverse limb and cardiovascular events,…
‘Voices of Vascular’ series celebrates Women’s History Month
The contributions of the Society for Vascular Surgery’s women members take center stage this month as part of the SVS Foundation’s “Voices of Vascular” series. The “Voices” series is designed to help celebrate the diversity in the vascular surgery specialty.…
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence of meaningful in-hospital adverse clinical outcomes compared to other contemporary treatments, data presented at the American…
Apply for Brandeis health policy program by March 15
Society for Vascular Surgery (SVS) members have until March 15 to apply for a scholarship to attend the Executive Leadership Program in Health Policy and Management at Brandeis University. The week-long program for physicians and surgeons will be June 4–10…